Man in remission from HIV1 three years after stem cell transplant from donor with CCR5 deletion


Published in New England Journal of Medicine.
Showing the critical role of a CCR5 deletion in resistance to HIV1 infection

http://www.nejm.org/doi/full/10.1056/NEJMoa0802905

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Gero Hütter, M.D et al.
N Engl J Med 2009; 360:692-698February 12, 2009

Infection with the human immunodeficiency virus type 1 (HIV-1) requires the presence of a CD4 receptor and a chemokine receptor, principally chemokine receptor 5 (CCR5). Homozygosity for a 32-bp deletion in the CCR5 allele provides resistance against HIV-1 acquisition.

Popular article covering this:
CNN
http://www.cnn.com/2010/HEALTH/12/14/hiv.infection.cure/index.html

By Tom Watkins, CNN
December 15, 2010 4:10 a.m. EST

….. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, called it impractical. “It’s hard enough to get a good compatible match for a transplant like this,” he said in a statement. “But you also have to find (a) compatible donor that has this genetic defect, and this defect is only found in 1% of the Caucasian population and 0% of the black population. This is very rare.”…
….. But AIDS researchers predicted the report will have little impact on practice.
“This probably is a cure, but it comes at a bit of a price,”….

Advertisements

Leave a comment

Filed under Health

Comments and Any Questions

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s